Company Analysis

Vivani Medical, Inc. (VANI)

Nasdaq: VANI · Electromedical & Electrotherapeutic Apparatus · Alameda, CA · filing with the SEC since 2003
Grade4.8
◀ Past 2.8● Present 4.5▶ Future 7.1
5 est.

Filings

352 filings since 2017 beside 324 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 43 days after the quarter ended. The proxy statement was last filed Apr 29, 2026.

Filings a yearinsider forms included
8851496477585547
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 4 times in the last 36 months, the newest Jun 30, 2026.Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Dec 27, 2023.SEC letters: 2 in the last 36 months, the newest May 2, 2024.
Insider forms 324

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 8-K items 2.02, 7.01, 8.01, 9.01 Results released; Investor disclosure (Regulation FD); Other event · Current report Nov 11, 2026
Nov 12, 2026 10-Q Quarterly report Sep 30, 2026
Oct 30, 2026 8-K item 7.01 Investor disclosure (Regulation FD) · Current report
Oct 29, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Sep 25, 2026 424B5 Shelf offering
Sep 16, 2026 8-K item 7.01 Investor disclosure (Regulation FD) · Current report
Aug 17, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 13, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Aug 13, 2026 10-Q Quarterly report Jun 30, 2026
Aug 6, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jul 16, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report Jul 15, 2026
Jul 7, 2026 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report Jul 1, 2026
Jun 30, 2026 8-K items 5.02, 5.07, 8.01, 9.01 Officer or director change; Shareholder vote; Other event · Current report Jun 24, 2026
Jun 4, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
May 19, 2026 SCHEDULE 13D/A Activist holder update, amended
May 13, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
May 13, 2026 10-Q Quarterly report Mar 31, 2026
Apr 29, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 29, 2026 DEFA14A Extra proxy material
Apr 29, 2026 DEF 14A Proxy statement Dec 31, 2025
Mar 26, 2026 8-K items 2.02, 9.01 Results released · Current report
Mar 26, 2026 10-K Annual report Dec 31, 2025
Jan 27, 2026 8-K items 1.01, 3.02, 7.01, 9.01 Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report Jan 25, 2026
Jan 27, 2026 424B5 Shelf offering
Nov 13, 2025 10-Q Quarterly report Sep 30, 2025
Nov 13, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Oct 28, 2025 8-K items 1.01, 3.02, 7.01, 9.01 Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report Oct 26, 2025
Oct 28, 2025 424B5 Shelf offering
Oct 3, 2025 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Sep 17, 2025 8-K items 8.01, 9.01 Other event · Current report
Sep 9, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Sep 4, 2025 8-K items 8.01, 9.01 Other event · Current report
Aug 13, 2025 10-Q Quarterly report Jun 30, 2025
Aug 13, 2025 8-K items 1.01, 2.02, 3.02, 7.01, 8.01, 9.01 Major agreement signed; Results released; Shares sold without registration; Investor disclosure (Regulation FD); Other event · Current report Aug 11, 2025
Aug 5, 2025 8-K items 2.02, 7.01, 8.01, 9.01 Results released; Investor disclosure (Regulation FD); Other event · Current report
Jun 25, 2025 8-K item 5.07 Shareholder vote · Current report Jun 24, 2025
Jun 17, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jun 11, 2025 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report
May 29, 2025 8-K items 8.01, 9.01 Other event · Current report
May 13, 2025 10-Q Quarterly report Mar 31, 2025
40 of 352 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton VANI · research, not advice